Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02359565
Title Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Children's Hospital Los Angeles RECRUITING Los Angeles California 90027 United States Details
Lucile Packard Children's Hospital Stanford University RECRUITING Palo Alto California 94304 United States Details
Children's Hospital Colorado RECRUITING Aurora Colorado 80045 United States Details
Children's National Medical Center SUSPENDED Washington District of Columbia 20010 United States Details
Children's Healthcare of Atlanta - Arthur M Blank Hospital RECRUITING Atlanta Georgia 30329 United States Details
Lurie Children's Hospital-Chicago SUSPENDED Chicago Illinois 60611 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Cincinnati Children's Hospital Medical Center RECRUITING Cincinnati Ohio 45229 United States Details
Children's Hospital of Pittsburgh of UPMC RECRUITING Pittsburgh Pennsylvania 15224 United States Details
Saint Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
Texas Children's Hospital RECRUITING Houston Texas 77030 United States Details
Hospital for Sick Children RECRUITING Toronto Ontario M5G 1X8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field